These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25974314)

  • 1. Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?
    Blum K; Thanos PK; Badgaiyan RD; Febo M; Oscar-Berman M; Fratantonio J; Demotrovics Z; Gold MS
    Expert Opin Biol Ther; 2015 Jul; 15(7):973-85. PubMed ID: 25974314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
    Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
    Blum K; Febo M; McLaughlin T; Cronjé FJ; Han D; Gold SM
    J Behav Addict; 2014 Sep; 3(3):149-56. PubMed ID: 25317338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
    Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
    J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Genetics and Function in Food and Substance Abuse.
    Blum K; Oscar-Berman M; Barh D; Giordano J; Gold M
    J Genet Syndr Gene Ther; 2013 Feb; 4(121):. PubMed ID: 23543775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.
    Blum K; Oscar-Berman M; Giordano J; Downs B; Simpatico T; Han D; Femino J
    J Genet Syndr Gene Ther; 2012 Oct; 3(4):. PubMed ID: 23264886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
    Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
    Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.
    Blum K; Febo M; Badgaiyan RD; Demetrovics Z; Simpatico T; Fahlke C; M OB; Li M; Dushaj K; Gold MS
    Curr Neuropharmacol; 2017; 15(1):184-194. PubMed ID: 27174576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
    Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
    J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.
    Blum K; Oscar-Berman M; Stuller E; Miller D; Giordano J; Morse S; McCormick L; Downs WB; Waite RL; Barh D; Neal D; Braverman ER; Lohmann R; Borsten J; Hauser M; Han D; Liu Y; Helman M; Simpatico T
    J Addict Res Ther; 2012 Nov; 3(5):139. PubMed ID: 23926462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems medicine research approach for studying alcohol addiction.
    Spanagel R; Durstewitz D; Hansson A; Heinz A; Kiefer F; Köhr G; Matthäus F; Nöthen MM; Noori HR; Obermayer K; Rietschel M; Schloss P; Scholz H; Schumann G; Smolka M; Sommer W; Vengeliene V; Walter H; Wurst W; Zimmermann US; ; Stringer S; Smits Y; Derks EM
    Addict Biol; 2013 Nov; 18(6):883-96. PubMed ID: 24283978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics.
    Blum K; Badgaiyan RD; Gold MS
    Cureus; 2015 Oct; 7(10):e348. PubMed ID: 26623203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curious cases: Altered dose-response relationships in addiction genetics.
    Uhl GR; Drgonova J; Hall FS
    Pharmacol Ther; 2014 Mar; 141(3):335-46. PubMed ID: 24189489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.
    Blum K; Badgaiyan RD; Agan G; Fratantonio J; Simpatico T; Febo M; Haberstick BC; Smolen A; Gold MS
    J Reward Defic Syndr; 2015; 1(1):65-68. PubMed ID: 26052557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.